Zepastine
| Code | Size | Price |
|---|
| TAR-T35302-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Zepastine is a biochemical.
CAS:
28810-23-3
Formula:
C22H26N2O3S
Molecular Weight:
398.52
Purity:
0.98
SMILES:
[H][C@]12CC[C@]([H])(C[C@H](C1)OC1c3ccccc3N(C)S(=O)(=O)c3ccccc13)N2C
References
Williams G, Blatchford C, Mitchell JP. Evaluation of Nasal Inlet Ports Having Simplified Geometry for the Pharmacopeial Assessment of Mass Fraction of Dose Likely to Penetrate Beyond the Nasopharynx: a Preliminary Investigation. AAPS PharmSciTech. 2018 Sep 17. doi: 10.1208/s12249-018-1179-9. [Epub ahead of print] PubMed PMID: 30225778.
Padmaja D W, Velayutham R, Roy KK. Structure Investigation, Enrichment Analysis and Structure-based Repurposing of FDA-approved Drugs as Inhibitors of BET-BRD4. J Biomol Struct Dyn. 2018 Aug 6:1-22. doi: 10.1080/07391102.2018.1507838. [Epub ahead of print] PubMed PMID: 30079805.
Abdelwahab NS, Farid NF, Elagawany M, Abdelmomen EH. Efficient UPLC and CE methods for the simultaneous determination of azelastine hydrochloride and its genotoxic impurity. Biomed Chromatogr. 2018 Jul 25:e4346. doi: 10.1002/bmc.4346. [Epub ahead of print] PubMed PMID: 30045415.
El-Masry AA, Hammouda MEA, El-Wasseef DR, El-Ashry SM. Eco-Friendly Green Liquid Chromatographic Determination of Azelastine in the Presence of its Degradation Products: Applications to Degradation Kinetics. J AOAC Int. 2018 Aug 10. doi: 10.5740/jaoacint.17-0472. [Epub ahead of print] PubMed PMID: 30097074.